Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| neuron | 7 studies | 44% ± 24% | |
| glutamatergic neuron | 5 studies | 34% ± 15% | |
| retinal ganglion cell | 4 studies | 76% ± 27% | |
| amacrine cell | 4 studies | 49% ± 18% | |
| OFF-bipolar cell | 3 studies | 51% ± 34% | |
| GABAergic amacrine cell | 3 studies | 38% ± 14% | |
| GABAergic neuron | 3 studies | 32% ± 9% | |
| oligodendrocyte precursor cell | 3 studies | 30% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 2183.23 | 2566 / 2642 | 86% | 12.53 | 609 / 705 |
| adrenal gland | 3% | 9.03 | 9 / 258 | 64% | 10.54 | 148 / 230 |
| esophagus | 0% | 0 | 0 / 1445 | 41% | 0.79 | 75 / 183 |
| intestine | 6% | 10.72 | 59 / 966 | 16% | 0.25 | 82 / 527 |
| stomach | 0% | 0 | 0 / 359 | 16% | 0.27 | 46 / 286 |
| lung | 0% | 0 | 0 / 578 | 15% | 0.25 | 178 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 14% | 0.25 | 69 / 504 |
| ovary | 0% | 0 | 0 / 180 | 13% | 0.27 | 58 / 430 |
| uterus | 0% | 0 | 0 / 170 | 10% | 0.18 | 46 / 459 |
| pancreas | 0% | 0 | 0 / 328 | 9% | 0.17 | 16 / 178 |
| kidney | 0% | 0 | 0 / 89 | 8% | 0.12 | 69 / 901 |
| breast | 0% | 0 | 0 / 459 | 8% | 0.24 | 85 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
| skin | 0% | 0.14 | 1 / 1809 | 6% | 0.10 | 27 / 472 |
| liver | 0% | 0 | 0 / 226 | 3% | 0.05 | 13 / 406 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.23 | 2 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.04 | 1 / 45 |
| prostate | 0% | 0 | 0 / 245 | 2% | 0.03 | 9 / 502 |
| thymus | 0% | 0 | 0 / 653 | 1% | 0.01 | 4 / 605 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
| GO_0044297 | Cellular component | cell body |
| GO_0005834 | Cellular component | heterotrimeric G-protein complex |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0014069 | Cellular component | postsynaptic density |
| GO_0030425 | Cellular component | dendrite |
| GO_0031681 | Molecular function | G-protein beta-subunit binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | GNG3 |
| Protein name | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 |
| Synonyms | GNGT3 |
| Description | FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems. The beta and gamma chains are required for the GTPase activity, for replacement of GDP by GTP, and for G protein-effector interaction. |
| Accessions | ENST00000294117.6 P63215 |
